Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Form 8.5 (EPT/RI)

11 Apr 2022 09:06

RNS Number : 9438H
Singer Capital Markets Sec Ltd
11 April 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

BRAND ARCHITEKTS GROUP PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

BRAND ARCHITEKTS GROUP PLC

(d) Date dealing undertaken:

08 April 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

If YES, specify which:

 

InnovaDerma PLC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 5P

 

 

Sale

 

5,000

 

81.6p

 

81.6p

 

ORD 5P

 

 

Purchase

 

23,169

 

80p

 

77.96p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

11 April 2022

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUARWRUVUSARR
Date   Source Headline
25th Feb 20107:00 amRNSHalf Yearly Report
19th Feb 20102:31 pmRNSHolding(s) in Company
27th Jan 201012:29 pmRNSHolding(s) in Company
3rd Dec 20093:20 pmRNSDirectorate Change
18th Nov 20094:28 pmRNSHolding(s) in Company
13th Nov 20093:17 pmRNSHolding(s) in Company
5th Nov 20093:28 pmRNSAGM Statement
3rd Nov 200912:05 pmRNSDirectorate Change
27th Oct 20094:33 pmRNSTotal Voting Rights
15th Oct 20092:06 pmRNSExercise of options and Directors' dealing
8th Oct 20094:37 pmRNSPosting of Annual Report and Accounts
10th Sep 20097:00 amRNSFinal Results
26th Feb 20097:00 amRNSHalf Yearly Report
12th Jan 20097:00 amRNSChange of Adviser
24th Nov 20084:24 pmRNSDirector/PDMR Shareholding
7th Nov 20087:00 amRNSAGM Statement
16th Oct 20081:50 pmRNSHolding(s) in Company
13th Oct 20084:41 pmRNSAnnual Report and Accounts
13th Oct 200810:13 amRNSDirectorate Change
17th Sep 200811:15 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSDirector/PDMR Shareholding
11th Sep 20087:00 amRNSFinal Results
5th Sep 200810:00 amRNSNotice of Results
15th Jul 20087:00 amRNSRe Joint Venture
2nd Jun 200812:07 pmRNSHolding(s) in Company
28th Feb 20087:01 amRNSInterim Results
15th Jan 200811:36 amRNSHolding(s) in Company
11th Jan 20087:01 amRNSNew Cosmetics Operation
10th Jan 20083:49 pmRNSDirector/PDMR Shareholding
7th Jan 200810:34 amRNSDirector/PDMR Shareholding
28th Dec 200711:38 amRNSSale and Leaseback
8th Nov 20072:43 pmRNSAGM Statement
7th Nov 20074:10 pmRNSHolding(s) in Company
2nd Nov 20075:31 pmRNSre nomination of directors
2nd Nov 20077:00 amPRNStatement re nomination of new Swallowfield directors
17th Oct 200711:33 amRNSDirector/PDMR Shareholding
16th Oct 20073:30 pmRNSAnnual Report and Accounts
15th Oct 20077:01 amRNSDirectorate Change
12th Oct 20073:48 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSFinal Results
5th Sep 200710:29 amRNSHolding(s) in Company
17th Aug 20074:46 pmRNSAIM Rule 26
15th Jun 20073:45 pmRNSHolding(s) in Company
6th Jun 20077:01 amRNSTrading Statement
18th May 20074:29 pmRNSHolding(s) in Company
17th May 200712:21 pmRNSTrading Update
23rd Apr 200710:56 amRNSHolding(s) in Company
13th Apr 20072:47 pmRNSHolding(s) in Company
2nd Mar 20077:30 amRNSInterim Results
6th Feb 200712:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.